Published in Drug Law Weekly, January 16th, 2007
Under the terms of the agreement, which has an initial term of 5 years, Biovail will compensate Sciele for providing detailing and sampling support for the products. In addition, Sciele is entitled to incentive fees if certain baseline revenue targets are met.
A promotional services agreement was contemplated in Biovail's recently issued 2007 financial guidance. As such, no...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.